ARP Keynote: Ethical Quandaries with COVID-19 Vaccines

Saturday, November 6, 2021

2:00 PM – 3:00 PM ET

Moderator(s)

Christine Stamatos, DNP, ANP-C

Northwell Health, Division of Rheumatology, United States

Disclosure: I have no relevant financial relationship(s) with ineligible companies to disclose.

All of the relevant financial relationships listed for faculty have been mitigated.

Session Overview: The speaker will discuss ethical issues in vaccine development, roll-out, and utilization, focusing on COVID-19 vaccines. Urgency due to the global pandemic and scientific progress led to rapid development and deployment of vaccines which presented ethical challenges. Almost a year after the authorization of novel COVID-19 vaccines, the speaker will discuss the state of vaccine distribution, what we know about the duration of effect, safety, and efficacy in persons with autoimmune disorders and in children, and ethical challenges in global distribution.

Learning Objectives:

Describe the ethical decision points in the trajectory of vaccine research and testing, with specific attention to COVID-19 vaccines
Discuss ethical frameworks guiding COVID-19 vaccine allocation and distribution, including global distribution, and the challenges encountered
Consider ethical issues related to vaccine utilization and responses to responses to vaccine hesitancy and uncertainty

Presentations:

2:00 PM – 2:45 PM ET

ARP Keynote: Ethical Quandaries with COVID-19 Vaccines
Speaker: Christine Grady, PhD, MSN – National Institutes of Health Clinical Center - Bioethics Department
2:45 PM – 3:00 PM ET

Q&A
Q&A Moderator: Christine Stamatos, DNP, ANP-C – Northwell Health, Division of Rheumatology
Q&A Presenter: Christine Grady, PhD, MSN – National Institutes of Health Clinical Center - Bioethics Department